UPDATE 1-Abbott bowel drug meets late-stage trial goal

n"May 10 (Reuters) - Abbott Laboratories said its drug, Humira, to treat ulcerative colitis, a form of inflammatory bowel disease, met the main goal of a late-stage trial. In the eighth week, 16.5 percent...